841 related articles for article (PubMed ID: 27012984)
1. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
2. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
Xi H; Yang Z; Tatavarti A; Xu W; Fuerst J; Ormes J
Int J Pharm; 2019 Jan; 554():48-53. PubMed ID: 30236644
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
4. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
5. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
6. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
7. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
[TBL] [Abstract][Full Text] [Related]
8. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
Agrawal AM; Dudhedia MS; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
[TBL] [Abstract][Full Text] [Related]
9. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
[TBL] [Abstract][Full Text] [Related]
10. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study.
Sakurai A; Sakai T; Sako K; Maitani Y
Chem Pharm Bull (Tokyo); 2012; 60(4):459-64. PubMed ID: 22466729
[TBL] [Abstract][Full Text] [Related]
11. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
13. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method.
Hanada M; Jermain SV; Williams RO
J Pharm Sci; 2018 Jan; 107(1):362-371. PubMed ID: 28989021
[TBL] [Abstract][Full Text] [Related]
15. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
16. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
17. Interactions between drugs and polymers influencing hot melt extrusion.
Li Y; Pang H; Guo Z; Lin L; Dong Y; Li G; Lu M; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):148-66. PubMed ID: 24325738
[TBL] [Abstract][Full Text] [Related]
18. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
19. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
20. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
